Kindly MD

Kindly MD EBITDA per Share

The EBITDA per Share of Kindly MD (NAKA) as of Nov 4, 2026 is -3.97 USD. In the previous year, EBITDA per Share was -0.51 USD — a change of 676.15% (lower).

EBITDA per Share

-3.97USD

YoY

676.15%

Last updated:

EBITDA per Share of Kindly MD is 2025 -3.97 USD. EBITDA per Share of Kindly MD was 2024 -0.51 USD. It decreases by 676.15% lower compared to the previous year.

The Kindly MD EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2021
0.01 USD
Jan 1, 2022
-0.45 USD
Jan 1, 2023
-0.25 USD
Jan 1, 2024
-0.51 USD
Jan 1, 2025
-3.97 USD
The Kindly MD EBITDA per Share history
YEAREBITDA per ShareYoY
-3.97USD+676.15%
-0.51USD+101.88%
-0.25USD-43.77%
-0.45USD-4,490.98%
0.01USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Kindly MD Stock analysis

What does Kindly MD do? Kindly MD, Inc. generates revenue through fee-for-service healthcare offerings including evaluation and management for chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support services, overdose education, peer support, limited urgent care, preventative medicine, medically managed weight loss, and hormone therapy. The company integrates prescription medicine and behavioral health services to reduce opioid use among chronic pain patients. Data collection on patient treatment alternatives to reduce prescription medication use and addiction supports their clinical approach and informs their service offerings. The firm serves chronic pain patients seeking integrated care solutions that address both physical and behavioral health needs. Patients engage with Kindly MD, Inc. for comprehensive treatment plans that combine medical and psychological support. The company's focus on reducing opioid dependency through alternative treatment pathways attracts individuals looking for non-addictive pain management options. Kindly MD, Inc. offers specialty outpatient clinical services on a fee-for-service basis, with no mention of insurance partnerships or government contracts. The business model relies on direct patient payments for services rather than third-party reimbursement. Their data-driven approach to patient care helps tailor treatments and may support future service development based on collected insights. Kindly MD is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Kindly MD stock

EBITDA per Share of Kindly MD is -3.97 USD in 2025.

EBITDA per Share of Kindly MD changed from -0.51 USD to -3.97 USD, representing a 676.15% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Kindly MD since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Kindly MD

All Key Metrics — Kindly MD